KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹170 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹126 Cr |
| Mar2022 | ₹139 Cr |
| Mar2021 | ₹78 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹170 Cr | 11.63 | |
| Mar2024 | ₹152 Cr | 20.57 | |
| Mar2023 | ₹126 Cr | -9.71 | |
| Mar2022 | ₹139 Cr | 78.16 | |
| Mar2021 | ₹78 Cr | - | |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,615.3 Cr | 8.4% | 4% | 71.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 8.4% |
4% |
71.3% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses